Abstract: The sensors capable of measuring a wide range of pressures at high temperatures are critically needed in the industrial fields. We propose an optical fiber tip probe pressure sensor based on ...

FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.

Optic neuritis, a common multiple sclerosis symptom, causes vision loss due to optic nerve inflammation. This experimental therapy aims to protect vision and nerve structure; a global Phase 3 trial is ...

Please provide your email address to receive an email when new articles are posted on . If approved, privosegtor would become the first neuroprotective therapy for optic neuropathies. The PIONEER 1 ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Oculis Holding (OCS) added ~11% on Tuesday after the Swiss drug developer announced the breakthrough therapy designation for its eye disease therapy Privosegtor as a treatment for optic neuritis (ON), ...

Abstract: Robots have taken the place of human operators in hazardous and challenging jobs requiring high dexterity in manipulation, and robots with skin for force and tactile sensing that mimics the ...